Prof. Dr. Karl Lauterbach is the new German health minister
On 6 December 2021, Prof. Dr. Karl Lauterbach was announced as the new German health minister. This might mean quite a lot
Category: Early benefit assessments
New government coalition plans AMNOG, pricing and other reforms
The new government in Germany is formed as a coalition of the three parties, SDP, FDP and the Green Party. At the
G-BA assessment of orphan drug gene therapies, Zolgensma and Libmeldy
The gene therapies Zolgensma and Libmeldy, both, are targeting very rare, severe, genetic diseases in children. The G-BA has now assessed the
Who are the members of the G-BA?
The G-BA has 13 voting members forming the so-called plenum. The representatives of care providers are only entitled to vote on topics
ITC was accepted and improved additional benefit rating
In the recent early benefit assessment of nivolumab, the G-BA not only accepted the submitted ITC, but this also resulted in a